A phase 3 clinical trial on the immunogenicity and safety of booster vaccination after Zagreb or Essen regimens.
Ontology highlight
ABSTRACT: The Zagreb and Essen regimens are comparable in terms of immunogenicity; however, how these regimens impact the immunogenicity of booster vaccination remains unknown. We conducted a clinical trial to assess the immunogenicity of booster vaccination with a purified Vero cell rabies vaccine after primary vaccination with the Zagreb or Essen regimens. This randomized, open-label, controlled, phase 3 trial, conducted in Shangyu City and Shengzhou City, Zhejiang Province, China, was divided into the primary and booster vaccination phases. After screening, all eligible participants were allocated to groups A, B, C, D, E, or F. Groups A, B, and C received the Zagreb regimen as the primary vaccine, while groups D, E, and F received the Essen regimen. The booster vaccination was conducted 6 months
SUBMITTER: Lv HK
PROVIDER: S-EPMC11868620 | biostudies-literature | 2025 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA